As of 2025-12-20, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 50.96 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -56.2%.
The range of the Relative Valuation is 45.06 - 73.22 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 35.0x | 27.2x |
| Forward P/E multiples | 20.1x - 31.8x | 21.7x |
| Fair Price | 45.06 - 73.22 | 50.96 |
| Upside | -61.3% - -37.0% | -56.2% |
| Date | P/E |